The groundbreaking treatment of the medication represents a significant advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide790777.spintheblog.com/42344496/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment